icd10coded.com
  • ICD-10 CM
    • ICD-10 CM Diagnosis Codes
    • Convert ICD-9 to ICD-10
    • Index of Diseases and Injuries
    • Index of External Cause of Injuries
    • Table of Neoplasms
    • Table of Drugs & Chemicals
    • POA Reporting Guidelines
    • POA Codes
    • Diagnosis Related Groups - MS-DRG
  • ICD-10 PCS
    • ICD-10 PCS Procedure Codes
    • ICD-10 PCS Index
    • ICD-10 PCS Definitions
    • Device Aggregation Table
    • Diagnosis Related Groups - MS-DRG
  • Coding Rules
    • Perinatal/Newborn diagnoses
    • Pediatric diagnoses
    • Maternity diagnoses
    • Adult diagnoses
    • Diagnoses for females only
    • Diagnoses for males only
    • Procedures for females only
    • Procedures for males only
    • Unacceptable principal diagnosis
    • Questionable admission codes
    • Manifestation code as principal diagnosis
  • Clinical Concept
    • Allergy
    • Cardiology
    • Endocrinology
    • Family Practice
    • Internal Medicine
    • OB/GYN
    • Orthopedics
    • Pediatrics
    • Physical Therapy
  • Search
  1. Home
  2. ICD-10 CM
  3. C69.50
  4. Feedback

ICD-10 Code C69.50
Malignant neoplasm of unspecified lacrimal gland and duct

C69.50 is a specific ICD-10-CM code used to designate a malignant neoplasm of an unspecified lacrimal gland and duct. The lacrimal system plays a crucial role in producing and draining tears, and primary malignancies within these structures are rare but aggressive forms of orbital cancers. The most common histological subtypes associated with this diagnosis include adenoid cystic carcinoma, adenocarcinoma, and carcinoma ex pleomorphic adenoma. Patients presenting with a lacrimal gland or duct tumor often report a palpable upper eyelid mass, globe displacement or proptosis, localized pain, double vision, or altered tear production. This code applies to primary cancerous growths of the lacrimal apparatus when the specific laterality or detailed ductal location is not stated in the medical record, and it encompasses related conditions such as lacrimal duct carcinoma, malignant mixed tumors of the lacrimal gland, and invasive orbital neoplasms of lacrimal origin.


C69.50 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of unspecified lacrimal gland and duct. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.


See also, ICD-10 Table of Neoplasms.

MS-DRG - Medicare Severity-Diagnosis Related Group
  • MDC 02 Diseases & Disorders of the Eye
    Other Disorders of the Eye
    • DRG 124 - OTHER DISORDERS OF THE EYE WITH MCC
    • DRG 125 - OTHER DISORDERS OF THE EYE WITHOUT MCC

Coding structure:

ICD-10 code C69.50 is based on the following Tabular structure:

Chapter 2: Neoplasms
  • Section C69-C72: Malignant neoplasms of eye, brain and other parts of central nervous system
    • Category C69: Malignant neoplasm of eye and adnexa

↑ Parent code:
C69.5 for Malignant neoplasm of lacrimal gland and duct

C69.50__
Category
 
Etiology, Anatomic Site,
Severity, Other Vital Details
Extension

Should you use C69.50 or C6950 (with or without decimal point) when submitting claims?

DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.

Section C69-C72 — Malignant neoplasms of eye, brain and other parts of central nervous system
  1. C69 Malignant neoplasm of eye and adnexa

    Excludes1

    • malignant neoplasm of connective tissue of eyelid (C49.0)
    • malignant neoplasm of eyelid (skin) (C43.1-, C44.1-)
    • malignant neoplasm of optic nerve (C72.3-)
    1. C69.0 Malignant neoplasm of conjunctiva

      1. C69.00 Malignant neoplasm of unspecified conjunctiva

      2. C69.01 Malignant neoplasm of right conjunctiva

      3. C69.02 Malignant neoplasm of left conjunctiva

    2. C69.1 Malignant neoplasm of cornea

      1. C69.10 Malignant neoplasm of unspecified cornea

      2. C69.11 Malignant neoplasm of right cornea

      3. C69.12 Malignant neoplasm of left cornea

    3. C69.2 Malignant neoplasm of retina

      1. C69.20 Malignant neoplasm of unspecified retina

      2. C69.21 Malignant neoplasm of right retina

      3. C69.22 Malignant neoplasm of left retina

    4. C69.3 Malignant neoplasm of choroid

      1. C69.30 Malignant neoplasm of unspecified choroid

      2. C69.31 Malignant neoplasm of right choroid

      3. C69.32 Malignant neoplasm of left choroid

    5. C69.4 Malignant neoplasm of ciliary body

      1. C69.40 Malignant neoplasm of unspecified ciliary body

      2. C69.41 Malignant neoplasm of right ciliary body

      3. C69.42 Malignant neoplasm of left ciliary body

    6. C69.5 Malignant neoplasm of lacrimal gland and duct

      Inclusion term(s):

      • Malignant neoplasm of lacrimal sac
      • Malignant neoplasm of nasolacrimal duct
      1. C69.50 Malignant neoplasm of unspecified lacrimal gland and duct

      2. C69.51 Malignant neoplasm of right lacrimal gland and duct

      3. C69.52 Malignant neoplasm of left lacrimal gland and duct

    7. C69.6 Malignant neoplasm of orbit

      Inclusion term(s):

      • Malignant neoplasm of connective tissue of orbit
      • Malignant neoplasm of extraocular muscle
      • Malignant neoplasm of peripheral nerves of orbit
      • Malignant neoplasm of retrobulbar tissue
      • Malignant neoplasm of retro-ocular tissue
      1. C69.60 Malignant neoplasm of unspecified orbit

      2. C69.61 Malignant neoplasm of right orbit

      3. C69.62 Malignant neoplasm of left orbit

    8. C69.8 Malignant neoplasm of overlapping sites of eye and adnexa

      1. C69.80 Malignant neoplasm of overlapping sites of unspecified eye and adnexa

      2. C69.81 Malignant neoplasm of overlapping sites of right eye and adnexa

      3. C69.82 Malignant neoplasm of overlapping sites of left eye and adnexa

    9. C69.9 Malignant neoplasm of unspecified site of eye

      Inclusion term(s):

      • Malignant neoplasm of eyeball
      1. C69.90 Malignant neoplasm of unspecified site of unspecified eye

      2. C69.91 Malignant neoplasm of unspecified site of right eye

      3. C69.92 Malignant neoplasm of unspecified site of left eye

Abbreviations used here:

NEC Not elsewhere classifiable
This abbreviation in the Tabular List represents “other specified”. When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code.

NOS Not otherwise specified
This abbreviation is the equivalent of unspecified.

This note further define, or give examples of, the content of the code or category.

List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.

A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

Feedback

Finding the right ICD-10 code is not always easy. Submitting the wrong code can cause delays in processing claims and payments. Please let us know if there is anything we can do better to help make your job easier. We strive to be the best ICD-10 site possible.

Share this page

Was the information found on this page useful? Share this page with a friend or colleague. They may also find it useful. We can send an email to someone you designate with this information as well.

  • ICD-10 CM
  • ICD-10 PCS
  • FAQs
  • Sitemap
  • →
  • Terms of Use
  • Privacy Policy
  • Contact Us
Follow @icd10coded

ICD-10 data provided by CMS (Centers for Medicare & Medicaid Services). All content is provided “AS IS”. The latest version of ICD-10 is updated each year on October 1.

1.261103a — Privacy Settings